Sign in

Anna Nemudraia

@anemudraia.bsky.social
36 followers 54 following 2 posts

Doing my best and a bit of science. UF CoM, nemudryi-lab.com scholar.google.com/citations?hl=en&…

PostsRepliesMedia
Reposted by Anna Nemudraia
Luuk Loeff @lloeff.bsky.social · 14/05/2026
Happy to share our latest pre-print on the Druantia defense system. We find that Type III Druantia uses a cooperative helicase-nuclease mechanism to sense and degrade replication-associated forked DNA structures. www.biorxiv.org/content/10.6... A🧵
biorxiv.org
55329
Reposted by Anna Nemudraia
Artem Nemudryi @artemnemudryi.bsky.social · 08/04/2026
‼️Please share‼️ Nemudryi lab is looking for postdocs to join our team and study: 🦠 Bacterial phage defense mechanisms 🧬 RNA repair & CRISPR-based RNA editing Excited about RNA, host-virus interactions & mechanistic biology? Let's talk! Apply: explore.jobs.ufl.edu/en-us/job/53...
explore.jobs.ufl.edu
University of Florida - Details - Postdoctoral Associate
01913
Reposted by Anna Nemudraia
Harmit Singh Malik @harmitmalik.bsky.social · 11/03/2026
Bacterial Schlafen proteins mediate phage defence (new work from @anemudraia.bsky.social and @artemnemudryi.bsky.social labs) www.nature.com/articles/s41... Schlafens are an ancient, mechanistically conserved family of tRNA-targeting immune effectors.
nature.com
Bacterial Schlafen proteins mediate phage defence - Nature Microbiology
This study highlights that Schlafens are ancient, mechanistically conserved immune effectors that mediate antiviral immunity in organisms ranging from humans to bacteria.
13211
Reposted by Anna Nemudraia
Artem Nemudryi @artemnemudryi.bsky.social · 09/03/2026
Our work on bacterial Schlafens in phage defense is out today @natmicrobiol.nature.com! Check out the final version here: rdcu.be/e7Bmz We are looking for postdocs and students to expand our team! Official postings are coming soon. Please reach out if you're interested! #phage #phagesky #microsky
rdcu.be
Bacterial Schlafen proteins mediate phage defence
Nature Microbiology - This study highlights that Schlafens are ancient, mechanistically conserved immune effectors that mediate antiviral immunity in organisms ranging from humans to bacteria.
06131
Reposted by Anna Nemudraia
Luuk Loeff @lloeff.bsky.social · 18/08/2025
Exciting times ahead! Today marks the first day of the Loeff Lab at Leiden University Medical Center in the Netherlands 🇳🇱. I’m thrilled to begin this new adventure and continue exploring microbial defense mechanisms and their applications through an integrative structural biology approach.
10659
Reposted by Anna Nemudraia
henriqueswill.bsky.social @henriqueswill.bsky.social · 18/06/2025
New preprint from the Wiedenheft lab! We used #cryoEM to show how a type I-F #CRISPR integrase captures, delivers, and integrates foreign DNA. www.biorxiv.org/content/10.1...
A schematic of a bacterial cell being infected by a phage, with the Cas operon and CRISPR locus detailed. The Cas1-2/3 integrase adopts distinct conformations during the capture, delivery, and integration of a short fragment of the phage DNA.
151
Reposted by Anna Nemudraia
Artem Nemudryi @artemnemudryi.bsky.social · 25/07/2025
First preprint from the Nemudryi Lab! 🍾 In this work, we link antiviral immunity in bacteria and humans by showing that homologs of human Schlafen nucleases protect bacteria from phages. www.biorxiv.org/content/10.1...
biorxiv.org
Bacterial Schlafens mediate anti-phage defense
Human Schlafen proteins restrict viral replication by cleaving tRNA, thereby suppressing protein synthesis. Although the ribonuclease domain of Schlafen proteins is conserved across all domains of lif...
35128
Reposted by Anna Nemudraia
Artem Nemudryi @artemnemudryi.bsky.social · 25/07/2025
@anemudraia.bsky.social and I are grateful to our very first team members, Veronica, Yimo, and Riley, who bravely joined the lab early on and worked hard on this project! And big thanks to our collaborators, @lloeff.bsky.social and @kirillemedvedev.bsky.social. Excited for what’s next!
051
Reposted by Anna Nemudraia
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 24/05/2025
David Liu @harvard.edu beautifully articulates the criticality of basic science funding for developing revolutionary therapeutics like life-saving base editors 👏 youtu.be/8YhJM6zxYDw?...
youtu.be
Breakthrough Prize-Winning Biochemist on the Deadly Cost of Funding Cuts | Amanpour and Company
YouTube video by Amanpour and Company
1240102